Clinical trial
Characterizing Response to Antipsychotics in Schizophrenia
NCT06159322
Study timeline
Study start (actual)2023-01-01Date precision: day
Registry last updated2023-12-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
OlanzapineDRUG
ClozapineDRUG
Sponsors & collaborators
The Royal Ottawa Mental Health Centrelead sponsor
The Royal's Institute of Mental Health Researchcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06159322 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.